Carvedilol and the Food and Drug Administration (FDA) Approval Process: The FDA Paradigm and Reflections on Hypothesis Testing
- 28 February 1999
- journal article
- Published by Elsevier BV in Controlled Clinical Trials
- Vol. 20 (1), 16-39
- https://doi.org/10.1016/s0197-2456(98)00054-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- End-Point Interpretation in Clinical Trials: The Case for DisciplineControlled Clinical Trials, 1999
- Carvedilol and the Food and Drug Administration Approval ProcessControlled Clinical Trials, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Sequential Trials, Sequential Analysis and the Likelihood PrincipleThe American Statistician, 1966